热门话题-Zydus以1.66亿美元收购Assertio Holdings后,该公司股价上涨

路透中文
May 13
热门话题-Zydus以1.66亿美元收购Assertio Holdings后,该公司股价上涨

5月13日 - ** 制药公司Assertio Holdings(ASRT.O)的股价在盘前交易中上涨3.7%,至23.38美元

** ASRT 表示, (link) 印度制药商 Zydus Lifesciences ZYDU.NS 将以每股 23.50 美元(总计 1.664 亿美元)的价格收购该公司

** ASRT表示,Zydus Lifesciences旗下子公司Zydus Worldwide DMCC提出的报价,高于Assertio此前与Garda Therapeutics达成的合并协议

** 通过此次交易,Zydus将获得8种已获FDA批准、用于治疗多种疾病的药物

** Zydus的报价较ASRT最新收盘价溢价4%

** Assertio表示,该报价较Garda于4月宣布的每股18美元现金要约溢价30.6%,较Garda于5月4日宣布的修订后每股21.80美元要约溢价7.8%

** Assertio表示,该交易预计将于2026年第二季度完成

** 截至上次收盘,ASRT今年以来累计上涨148%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10